Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Issue Section
Date
Availability
1-3 of 3
Keywords: Tumour marker
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
A Unique Case of Bilateral Testicular Tumours: Nonseminomatous Germ Cell Tumour and Contralateral Spermatocytic Tumour 27 Years Apart
Available to PurchaseSubject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (2025) 109 (3): 307–310.
Published Online: 21 November 2024
... later when aged 56 years, he developed a lump in the left testis. Serum tumour markers including microRNA-371a-3p were within normal limits. Orchiectomy was performed. Histology revealed a spermatocytic tumour with positive stainings of SALL4, NUT, and CD117. No germ cell neoplasia in situ (GCNis...
Journal Articles
Testicular Cancer: B5, a New Tumour Marker
Available to PurchaseSubject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (1987) 42 (4): 254–259.
Published Online: 02 February 2010
...Su Metcalfe; W.G. Jones Tumour markers which occur in blood or urine are of value in the management of cancer patients because they allow disease status to be monitored by non-invasive techniques at low cost. An antigen, ‘B5’, on erythrocytes has been shown to become enhanced when cancer develops...
Journal Articles
Diagnostic Value of Tumour Marker Regression Models in Stage 1 Marker-Positive Testicular Cancer
Available to PurchaseSubject Area:
Further Areas
Journal:
Urologia Internationalis
Urol Int (2004) 73 (4): 329–336.
Published Online: 13 December 2004
...Matthias May; Christian Helke; Thomas Nitzke; Matthias Seehafer; Horst Vogler; Bernd Hoschke The decay pattern and half-life period evaluation of serum tumour markers are useful parameters in the management of testicular cancer in clinic stage 1. α-Fetoprotein and human chorionic gonadotropin serum...